The safety and efficacy of transarterial chemoembolisation with bleomycin for hepatocellular carcinoma unresponsive to doxorubicin: a prospective single-centre study.
Clin Radiol
; 76(11): 864.e7-864.e12, 2021 11.
Article
in En
| MEDLINE
| ID: mdl-34452734
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bleomycin
/
Doxorubicin
/
Chemoembolization, Therapeutic
/
Carcinoma, Hepatocellular
/
Liver Neoplasms
/
Antibiotics, Antineoplastic
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Radiol
Year:
2021
Type:
Article